Acadia Healthcare Company, Inc. (ACHC) intrinsic value & 10-year financials
Acadia Healthcare Company, Inc. (ACHC) has a Graham intrinsic value of $29.21 per share. At $29.98 on Oct 17, 2026, the stock trades 3% above that value. Over the last 10 fiscal years revenue grew 1.8% a year to $3.3B, with an average return on invested capital of 1.4%.
- Graham intrinsic value
- $29.21
- Share price (Oct 17, 2026)
- $29.98
- Price vs Graham value
- 3% above
- Market cap
- $2.7B
- Revenue (FY2025)
- $3.3B
- Revenue growth (10-yr CAGR)
- 1.8%
- ROIC (10-yr avg)
- 1.4%
- Free cash flow (FY2025)
- -$439.9M
ACHC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $3.3B | -$1.1B | -$12.16 | -$439.9M | — | -23.2% |
| FY2024 | $3.2B | $255.6M | $2.78 | -$560.7M | — | 5.5% |
| FY2023 | $2.9B | -$21.7M | -$0.24 | $38.2M | — | -0.5% |
| FY2022 | $2.6B | $273.1M | $2.98 | $84.4M | — | 6.6% |
| FY2021 | $2.3B | $190.6M | $2.10 | $129.7M | — | 4.4% |
| FY2020 | $2.1B | -$672.1M | -$7.59 | $442.2M | — | -12.9% |
| FY2019 | $3.1B | $108.9M | $1.24 | $48.2M | 18.9% | 8.5% |
| FY2018 | $3.0B | -$175.8M | -$2.01 | $72.6M | 19.7% | 10.6% |
| FY2017 | $2.8B | $199.8M | $2.30 | $125.4M | 21.3% | 9.1% |
| FY2016 | $2.8B | $6.1M | $0.07 | $54.0M | 21.7% | 5.6% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Acadia Healthcare Company, Inc. has demonstrated mature, steady growth, with revenue compounding at 1.8% annually over the past decade.
Acadia Healthcare Company, Inc. has historically struggled to out-earn its cost of capital, averaging just 1.4% ROIC.
Acadia Healthcare Company, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Acadia Healthcare Company, Inc. is modeled at 1.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $29.21 per share.